[Hybrid percutaneous coronary intervention with drug-eluting stent in combination with bioresorbable vascular scaffolds for complex coronary lesions].
Drug-eluting stents (DES) have significantly improved the outcome of percutaneous coronary intervention (PCI); however, several concerns remain regarding late adverse events associated with the presence of a permanent rigid metallic cage that might impair the natural healing process of the coronary vessel wall. Recently, PCI with bioresorbable vascular scaffolds (BVS) has emerged as an interesting alternative with several potential advantages related to the complete resorption process that occurs within 3-5 years. As a consequence, it reduces the trigger for persistent inflammation, enables restoration of normal vessel reactivity and facilitates positive remodeling. However, current BVS have several limitations, including thicker and wider struts, less radial strength, and limited expansion. A hybrid strategy, combining the use of BVS and DES, is a novel approach that could be useful to avoid the limitations of currently available BVS, particularly in case of PCI for complex coronary lesions.We describe a case of hybrid percutaneous intervention with BVS in combination with DES for managing complex lesions unsuitable for pure scaffolding percutaneous coronary intervention.